Biochemistry
-
Vanderbilt basic science alum Q&A: Randy Perera
Randy Perera, Fellow'24, who worked in the biochemistry department and is now a scientist at the pharmaceutical and biotech company MilliporeSigma (Merck KGaA) sat down with us to discuss his experience studying basic science at Vanderbilt and how it played a role in his career. Read MoreJul. 29, 2024
-
Richard Caprioli Basic Sciences research award for technology education fund honors Caprioli’s rich teaching legacy
To honor and continue Richard Caprioli’s legacy of teaching technological advances, the Richard Caprioli Basic Sciences Research Award for Technology Education fund has been established to allow Ph.D. students in the biomedical sciences to attend focused educational experiences in a technology that they would otherwise not encounter in their graduate studies. Read MoreJul. 25, 2024
-
The Caprioli Way
It started with a hacksaw and a multimillion-dollar instrument. Richard Caprioli, then a postdoctoral fellow, was given the saw to cut the instrument in half during his first day of his postdoctoral studies. It was the day that Caprioli, now Stanford Moore Professor of Biochemistry, developed a desire to “do innovative things” with mass spectrometry instruments.” This yearning resulted in him becoming a pioneer of new mass spec techniques, including imaging mass spec. Read MoreJul. 8, 2024
-
Eminent biochemist Katrin Karbstein joins Vanderbilt University as professor of biochemistry
Leader in the field of ribosome biogenesis, Katrin Karbstein has joined the School of Medicine Basic Sciences as Ingram Professor of Cancer Research and professor of biochemistry. Her work has revealed the intricate details of ribosome biogenesis and revealed how misassembled ribosomes contribute to disease. She is also a community leader and mentor to emerging scholars. Read MoreJul. 8, 2024
-
NSF names 9 biomedical science students and alumni as 2024 graduate research fellows
The prestigious fellowship program assists exceptional graduate students pursuing research-based master’s and doctoral degrees across various fields, including science, technology, engineering, mathematics, STEM education and social sciences supported by NSF. Read MoreJun. 21, 2024
-
Putting the fun back in antifungals: new insights into Acanthamoeba drug targets
Acanthamoeba can cause diseases blinding keratitis, an infection of the eye, or granulomatous amebic encephalitis, a generally fatal infection of the brain and spinal cord. Antifungals that target the biosynthesis of fungal sterols, such as ergosterol, are often used as treatment, but the Acanthamoeba ergosterol biosynthetic pathway has been shown to differ significantly from that found in fungi. Read MoreJun. 12, 2024
-
Iverson named School of Medicine Basic Sciences associate dean for faculty
Tina Iverson, Louise B. McGavock Chair and Professor of pharmacology and biochemistry, will take the role of associate dean for faculty on July 1, 2024. Read MoreJun. 4, 2024
-
STOP the GAP: New cryo-ET package aims to fill in the ‘missing wedge’
Cryo-ET suffers from the “missing wedge” problem: as samples become more tilted, their thickness at the extremes is increased and sample penetration decreases. William Wan and collaborators describe the creation of a new subtomogram averaging package called STOPGAP. Read MoreJun. 3, 2024
-
Vanderbilt-discovered cancer killing compound is now available through Boehringer Ingelheim open science portal opnMe
By targeting a notoriously undruggable protein found in many cancers, the discovery of BI-0474 may pave the way for new cancer treatments. Shared on opnMe.com by Boehringer Ingelheim, this innovative molecule is available for global researchers to explore new research avenues. Read MoreMay. 28, 2024
-
Research Snapshot: Understanding protein mutations that affect gene expression
Foundational research from the Hiebert lab reveals genetic targets that can be leveraged to identify therapies that affect lymphoma cell growth. Read MoreMay. 23, 2024